Immunomodulatory and biologic therapies for severe refractory asthma

被引:19
|
作者
Polosa, Riccardo [1 ]
Morjaria, Jaymin [2 ]
机构
[1] UOC Med Interna & Med Urgenza, Osped Santa Marta, I-95124 Catania, Italy
[2] Univ Southampton, Dept IIR, Southampton, Hants, England
关键词
Severe asthma; Corticosteroids; Immunological modifiers; Steroid-sparing; Anti-TNFalpha drugs; Omalizumab;
D O I
10.1016/j.rmed.2008.09.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Despite undoubted efficacy of the combination of inhaled corticosteroids and beta(2)-agonists for most asthmatic patients with mode rate-to-severe disease, there remains similar to 10% of the asthmatic population with serious unremitting symptoms, resulting in considerable impact on quality of life, disproportionate use of health care resources, and adverse effects from regular systemic steroid use. In an ideal. world, optimal treatment of severe refractory asthma should achieve the best possible asthma control and quality of life with the [east dose of systemic corticosteroids. The choice and formulation of therapeutic agent are dictated by the severity of disease and may include immunological modifiers and biologic therapies. Unfortunately, current asthma guidelines offer little contribution to the management of the challenging patient with severe refractory asthma and none of them have addressed therapeutic alternatives to oral corticosteroids. This article reviews the current evidence for immunomodulating and biologic approaches in severe refractory asthma. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1499 / 1510
页数:12
相关论文
共 50 条
  • [1] Biologic Therapies for Severe Asthma
    Brusselle, Guy G.
    Koppelman, Gerard H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (02): : 157 - 171
  • [2] Biologic therapies in severe asthma
    Dupin, C.
    [J]. REVUE FRANCAISE D ALLERGOLOGIE, 2023, 63 (03):
  • [3] Severe asthma revisited by biologic therapies emergences
    Guilleminault, Laurent
    Didier, Alain
    [J]. PRESSE MEDICALE, 2019, 48 (03): : 310 - 321
  • [4] The Current State of Biologic Therapies for Treatment of Refractory Asthma
    Matthew Mavissakalian
    Sean Brady
    [J]. Clinical Reviews in Allergy & Immunology, 2020, 59 : 195 - 207
  • [5] The Current State of Biologic Therapies for Treatment of Refractory Asthma
    Mavissakalian, Matthew
    Brady, Sean
    [J]. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2020, 59 (02) : 195 - 207
  • [6] A pragmatic guide to choosing biologic therapies in severe asthma
    Kavanagh, Joanne E.
    Hearn, Andrew P.
    Jackson, David J.
    [J]. BREATHE, 2021, 17 (04)
  • [7] Clinical remission with biologic therapies in severe asthma: a matter of definition
    Beasley, Richard
    Noble, Jonathan
    Weatherall, Mark
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62 (06)
  • [8] Clinical remission with biologic therapies in severe asthma: a matter of definition
    McDowell, P. Jane
    McDowell, Ron
    Busby, John
    Eastwood, M. Chad
    Patel, Pujan H.
    Jackson, David J.
    Mansur, Adel
    Patel, Mitesh
    Burhan, Hassan
    Doe, Simon
    Chaudhuri, Rekha
    Gore, Robin
    Dodd, James W.
    Subramanian, Deepak
    Brown, Thomas
    Heaney, Liam G.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2024, 63 (06)
  • [9] Changing Paradigms in the Treatment of Severe Asthma: The Role of Biologic Therapies
    Katial, Rohit K.
    Bensch, Greg W.
    Busse, William W.
    Chipps, Bradley E.
    Denson, Joshua L.
    Gerber, Anthony N.
    Jacobs, Joshua S.
    Kraft, Monica
    Martin, Richard J.
    Nair, Parameswaran
    Wechsler, Michael E.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (02): : S1 - S14
  • [10] Biologic therapies for asthma
    Gruenberg, David
    Busse, William
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2010, 16 (01) : 19 - 24